The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
The clinical study of the lung cancel treated by sterotacticradiotherapy
Author(s): 
Pages: 22-23
Year: Issue:  14
Journal: Journal of Clinical Rehabilitative Tissue Engineering Research

Keyword:  肺癌 立体定向放疗;
Abstract: 目的 探讨立体定向放疗(SRT)治疗肺癌的方法和临床疗效。方法 采用SRT治疗与常规放疗(CFR)比较。结果 SRT组局部消退率88.5%(46/52),局部控制率92.3%(48/52),1年生存率63.5%(33/52)。CRF组:局部消退率64.9%(37/57),局部控制率75.4%(43/57),1年生存率42.1%(24/57),两组对照差异有显著意义(P<0.05)。结论 SRT治疗肺癌可缩短全程放疗时间,近期疗效明显,远期疗效有待扩大病例观察。
Related Articles
loading...